Neksium 40 mg Tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Neksium 40 mg Tablet contains esomeprazole 40 mg, a proton pump inhibitor (PPI). Its labelling describes it for conditions involving excess stomach acid — reducing the amount of acid the stomach produces, relieving symptoms and supporting healing.

Active ingredient
Esomeprazole
Strength
40 mg
Dosage form
Oral tablet
Therapeutic class
Proton pump inhibitor (PPI)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with esomeprazole and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Gastro-oesophageal reflux disease (GERD) and erosive oesophagitis
  • Peptic ulcers, including those related to NSAID use
  • Described as helping to prevent stomach ulcers associated with certain medicines such as NSAIDs
  • Zollinger–Ellison syndrome (a condition in which the stomach produces excess acid)
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Taken by mouth, preferably about one hour before a meal, at the dose and duration set by the prescriber
  • Treatment should be continued as prescribed even if symptoms improve, and should not be stopped suddenly without medical advice
  • Blood magnesium levels are described as needing to be checked when the medicine is taken for a long period

Described Side Effects

Commonly described side effects include:

  • Headache
  • Constipation or diarrhoea
  • Nausea
  • Stomach pain
  • Dizziness, drowsiness or blurred vision (caution with driving or using machinery until this settles)

These are described as tending to settle with time. A doctor should be consulted if they persist, and any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • Long-term use is described as being associated with an increased chance of bone fractures
  • Severe liver problems, HIV, or osteoporosis should be disclosed to the doctor before starting treatment
  • Rich, spicy or fatty foods, and caffeinated drinks such as tea, coffee and cola, as well as alcohol, are described as best avoided during treatment
  • Pregnant women and breastfeeding mothers should consult their doctor before taking the medicine

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains esomeprazole, a proton pump inhibitor, and is described for conditions involving excess stomach acid such as GERD, erosive oesophagitis, peptic ulcers (including NSAID-related) and Zollinger–Ellison syndrome. SDO Pharma has not independently verified these claims.

Its labelling describes it as taken preferably about one hour before a meal, at the dose and duration set by the prescriber. Treatment should not be stopped suddenly without medical advice, and magnesium levels are described as needing checking with long-term use.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services